Julia Festag

415 total citations
13 papers, 290 citations indexed

About

Julia Festag is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Julia Festag has authored 13 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Immunology and 7 papers in Hepatology. Recurrent topics in Julia Festag's work include Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (6 papers) and Hepatitis C virus research (6 papers). Julia Festag is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (6 papers) and Hepatitis C virus research (6 papers). Julia Festag collaborates with scholars based in Germany, France and United States. Julia Festag's co-authors include Ulrike Protzer, Anna D. Kosinska, Jinpeng Su, Katja Steiger, Percy A. Knolle, Frank Jaschinski, Sven Michel, Richard Klar, Marc Ringelhan and Thomas Michler and has published in prestigious journals such as Gastroenterology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Julia Festag

12 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Festag Germany 9 162 119 95 73 65 13 290
Ruth Simmons United Kingdom 8 63 0.4× 90 0.8× 54 0.6× 64 0.9× 58 0.9× 10 314
Wandi Zhu China 7 157 1.0× 86 0.7× 88 0.9× 134 1.8× 18 0.3× 9 332
Liangen Chen China 7 162 1.0× 295 2.5× 61 0.6× 39 0.5× 77 1.2× 10 427
Theresa Asen Germany 7 303 1.9× 148 1.2× 207 2.2× 73 1.0× 81 1.2× 11 424
James Ahodantin France 8 170 1.0× 58 0.5× 138 1.5× 77 1.1× 34 0.5× 15 287
Natalia Reszka-Blanco United States 7 212 1.3× 138 1.2× 123 1.3× 128 1.8× 28 0.4× 13 397
Christopher Dächert Germany 8 125 0.8× 68 0.6× 94 1.0× 75 1.0× 20 0.3× 16 256
Ludovic Aillot France 7 158 1.0× 76 0.6× 111 1.2× 136 1.9× 36 0.6× 8 331
Bradford Stanley United States 6 46 0.3× 73 0.6× 13 0.1× 179 2.5× 32 0.5× 7 318
G. Penne Belgium 10 128 0.8× 278 2.3× 16 0.2× 49 0.7× 65 1.0× 13 409

Countries citing papers authored by Julia Festag

Since Specialization
Citations

This map shows the geographic impact of Julia Festag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Festag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Festag more than expected).

Fields of papers citing papers by Julia Festag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Festag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Festag. The network helps show where Julia Festag may publish in the future.

Co-authorship network of co-authors of Julia Festag

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Festag. A scholar is included among the top collaborators of Julia Festag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Festag. Julia Festag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kosinska, Anna D., Martin Mück-Häusl, Chunkyu Ko, et al.. (2025). MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination. Molecular Therapy — Nucleic Acids. 36(3). 102641–102641.
2.
Michler, Thomas, et al.. (2024). The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice. Antiviral Research. 226. 105896–105896. 2 indexed citations
3.
Cianciaruso, Chiara, Ruben Bill, Marcel P. Trefny, et al.. (2023). Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for ImmunoTherapy of Cancer. 11(5). e006714–e006714. 14 indexed citations
4.
5.
Zhao, Lili, Marc Ringelhan, Karin Wisskirchen, et al.. (2021). Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane. Cellular Microbiology. 23(12). e13399–e13399. 6 indexed citations
6.
Ko, Chunkyu, Jinpeng Su, Julia Festag, et al.. (2021). Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors. Antiviral Research. 194. 105140–105140. 20 indexed citations
7.
8.
Festag, Julia, et al.. (2020). Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation. Molecular Therapy — Nucleic Acids. 21. 656–669. 12 indexed citations
9.
Michler, Thomas, Anna D. Kosinska, Julia Festag, et al.. (2020). Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice. Gastroenterology. 158(6). 1762–1775.e9. 92 indexed citations
10.
Festag, Julia, Simon P. Fräßle, Theresa Asen, et al.. (2019). Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model. Molecular Therapy. 27(5). 947–959. 41 indexed citations
11.
Kashyap, Abhishek S., Richard Klar, Sandra M. Kallert, et al.. (2019). Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for ImmunoTherapy of Cancer. 7(1). 67–67. 51 indexed citations
12.
Kosinska, Anna D., Julia Festag, Jinpeng Su, et al.. (2019). Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection. Scientific Reports. 9(1). 10808–10808. 26 indexed citations
13.
Bhattacharjee, Sonakshi, Antje Malo, Julia Festag, et al.. (2019). Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection. The Journal of Infectious Diseases. 221(9). 1448–1461. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Simmons Breakdown of academic impact, for papers by Wandi Zhu Breakdown of academic impact, for papers by Liangen Chen Breakdown of academic impact, for papers by Theresa Asen Breakdown of academic impact, for papers by James Ahodantin Breakdown of academic impact, for papers by Natalia Reszka-Blanco Breakdown of academic impact, for papers by Christopher Dächert Breakdown of academic impact, for papers by Ludovic Aillot Breakdown of academic impact, for papers by Bradford Stanley Breakdown of academic impact, for papers by G. Penne
Rankless by CCL
2026